| | |
| Clinical data | |
|---|---|
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C14H21N |
| Molar mass | 203.329 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
PCE (Eticyclidine, CI-400) is a dissociative anesthetic drug with hallucinogenic effects. It is similar in effects to phencyclidine but is slightly more potent. PCE was developed by Parke-Davis in the 1970s and evaluated for anesthetic potential under the code name CI-400, [2] but research into PCE was not continued after the development of ketamine, a similar drug with more favourable properties. [3] Due to its similarity in effects to PCP, PCE was placed into the Schedule 1 list of illegal drugs in the 1970s, although it was only briefly abused in the 1970s and 1980s and is now little known. [4]
| Inhalational | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Injection |
| ||||||||||||||
| |||||||||||||||
| D1-like |
| ||||||
|---|---|---|---|---|---|---|---|
| D2-like |
| ||||||
| AMPAR Tooltip α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor |
|
|---|---|
| KAR Tooltip Kainate receptor |
|
| NMDAR Tooltip N-Methyl-D-aspartate receptor |
|
| | This hallucinogen-related article is a stub. You can help Wikipedia by expanding it. |